HIGHLIGHTS
- who: Viviana Frantellizzi from the Experimental Sciences, University of Sassari, Sassari, Italy have published the research work: Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study, in the Journal: (JOURNAL)
- what: The aim of this study was to confirm the validity of already known prognostic factors and assess the prognostic value of other parameters. In the present analysis, the authors considered the 3-PS baseline study conducted in 2017 as a reference for the multicenter evaluation . This population includes the 92 patients from the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.